Though the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal cancers. Survival rates for myeloma, a bone marrow cancer, jumped from 32% to 62%, liver cancer from 7% to 22% and lung cancer from 15% to 28%.

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care, new data show.

An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA offered an accelerated approval path.

An annual report from the American Cancer Society shows that, for the first time, over 70% of Americans diagnosed with cancer can expect to live at least five years. The increase from the mid-1970s, when that number was just 49% is huge.

The Supreme Court said Friday that it will decide whether tens of thousands of people claiming the pesticide Roundup caused their cancer will have a day in court, or whether a federal law that regulates pesticide labeling will effectively block their cases from moving forward.

Only 183 patients referred for an urgent appointment with a breast cancer specialist were seen within 14 days between July and September 2025, according to latest figures from the Department of Health (DoH). That represents 3.5% patients who were referred for suspected breast cancer (5,309) across all five health and social care trusts.

The mother and daughter received identical diagnoses just over a year apart of multiple myeloma, a blood cancer that occurs when plasma cells become abnormal and produce dangerous proteins that can cause damage to our bones, kidneys and other functions.

Seven in 10 people now survive their cancer five years or more, up from only half in the mid-70s,” said Rebecca Siegel, senior scientific director of surveillance research at

Cancer survival rates climbed significantly in recent decades. But federal funding cuts could threaten that progress, physicians warn